Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 6/20 | 1.00 |
| ▸ | CPT2 | P23786 | 1/20 | 1.00 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2111332 | 1.00 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL6773065 | 1.00 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL17181773 | 1.00 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL17181757 | 1.00 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL2110910 | 1.00 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL27688847 | 1.00 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL108615 | 1.00 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL23068539 | 0.98 | ACLY (0.95) | ACLYCPT2HSPD1BLMHSPE1 | |
| Ammonia Solution, Strong SCHEMBL4780983 | 0.98 | ACLY (0.95) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL2821490 | 0.98 | ACLY (0.95) | ACLYCPT2HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023074894-A1 | CARTILAGE REGENERATION PROMOTER | 小林製薬株式会社 | 2023-05-04 | — | — | WO | claimed |
| CN-115006378-A | Medicine for preventing or treating metabolic diseases or metabolic dysfunction diseases | 西安莱格瑞生物科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| US-20150297545-A1 | ORGANIC ACIDS AS AGENTS TO DISSOLVE CALCIUM MINERALS IN PATHOLOGICAL CALCIFICATION AND USES THEREOF | UNIVERSITY OF HOUSTON SYSTEM (US) | 2015-10-22 | — | — | US | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-20020045769-A1 | Novel acyclic chiral derivatives of hibiscus acid and the process of preparing the same | DEPARTMENT OF SCIENCE AND TECHNOLOGY (IN) | 2002-04-18 | — | — | US | claimed |
| US-20260124237-A1 | CARTILAGE REGENERATION COMPOSITION | KOBAYASHI PHARMACEUTICAL CO LTD (JP) | 2026-05-07 | — | — | US | disclosed |
| WO-2023074893-A1 | CARTILAGE REGENERATION COMPOSITION | 小林製薬株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023074895-A1 | ORAL COMPOSITION | 小林製薬株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023074896-A1 | PHARMACEUTICAL OR FOOD COMPOSITION | 小林製薬株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023074894-A1 | CARTILAGE REGENERATION PROMOTER | 小林製薬株式会社 | 2023-05-04 | — | — | WO | disclosed |
| CN-115006378-A | Medicine for preventing or treating metabolic diseases or metabolic dysfunction diseases | 西安莱格瑞生物科技有限公司 | 2022-09-06 | — | — | CN | disclosed |
| US-9351956-B1 | Pharmaceutical composition comprising an enantiomer of lipoamide and derivatives thereof and method of use | GeroNova Research Inc. (US) | 2016-05-31 | — | — | US | disclosed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | disclosed |
| US-20120048295-A1 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2012-03-01 | — | — | US | disclosed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | disclosed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | disclosed |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | L'OREAL (FR) | 2009-01-29 | — | — | US | disclosed |
| US-20020045769-A1 | Novel acyclic chiral derivatives of hibiscus acid and the process of preparing the same | DEPARTMENT OF SCIENCE AND TECHNOLOGY (IN) | 2002-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | ACLY 588/4885CPT2 405/4885HSPD1 1631/4885 |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | CUTA, SYMPK, TPRKB | ACLY 336/4885CPT2 790/4885HSPD1 2726/4885 |
| US-20260124237-A1 | CARTILAGE REGENERATION COMPOSITION | CSGALNACT1, CD44, HCAR1 | ACLY 3090/4885CPT2 3121/4885HSPD1 158/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | ACLY 175/4885CPT2 200/4885HSPD1 2595/4885 |
| US-20020045769-A1 | Novel acyclic chiral derivatives of hibiscus acid and the process of preparing the same | ADH1A, ADH5, ADH1C | ACLY 681/4885CPT2 881/4885HSPD1 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.